Bristol-Myers Squibb BMY
CEO: Chris Boerner · Pharmaceuticals · 34,300 employees
Compensation Breakdown
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.9M | $683K | $14.3M | $3.0M | $2.4M | $140K | $22.6M |
| 2024 | $1.9M | — | $12.9M | $2.8M | $2.4M | $28K | $20.1M |
| 2023 | $1.9M | $220K | $7.2M | $3.1M | $1.7M | $88K | $14.4M |
| 2022 | $1.8M | — | $10.9M | $3.1M | $1.1M | $111K | $17.4M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Frequently Asked Questions
Chris Boerner, CEO of Bristol-Myers Squibb (BMY), earns $22.6M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Bristol-Myers Squibb has a Pay-for-Performance Score of D (35/100). The company's 3-year total shareholder return is -6.5%, and the say-on-pay shareholder vote passed with 72.2% approval.
The CEO-to-median-worker pay ratio at Bristol-Myers Squibb is 412:1. The median worker at Bristol-Myers Squibb earns $55K per year, while CEO Chris Boerner earns $22.6M in total compensation.
Bristol-Myers Squibb employs approximately 34,300 people. The company operates in the Pharmaceuticals industry within the Healthcare sector, generating $45.0B in annual revenue.